OAM
RARX
Oxford Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $22.1M | Buy |
461,016
+75,038
| +19% | +$3.6M | 3.12% | 7 |
|
|
2019
Q4 | $18.1M | Buy |
+385,978
| New | +$18.1M | 0.5% | 20 |
|
|
2019
Q2 | – | Sell |
-80,681
| Closed | -$1.81M | – | 2074 |
|
|
2019
Q1 | $1.81M | Sell |
80,681
-27,911
| -26% | -$625K | 0.04% | 622 |
|
|
2018
Q4 | $1.98M | Buy |
108,592
+17,418
| +19% | +$317K | 0.05% | 469 |
|
|
2018
Q3 | $1.66M | Buy |
91,174
+54,617
| +149% | +$991K | 0.03% | 769 |
|
|
2018
Q2 | $366K | Sell |
36,557
-114,394
| -76% | -$1.15M | 0.01% | 1442 |
|
|
2018
Q1 | $802K | Buy |
150,951
+92,946
| +160% | +$494K | 0.02% | 1040 |
|
|
2017
Q4 | $493K | Sell |
58,005
-10,421
| -15% | -$88.6K | 0.01% | 1184 |
|
|
2017
Q3 | $1.01M | Buy |
68,426
+1,088
| +2% | +$16.1K | 0.02% | 936 |
|
|
2017
Q2 | $1.26M | Buy |
+67,338
| New | +$1.26M | 0.03% | 807 |
|